1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Research Frontiers Inc. Reports Operating Results (10-Q)

August 07, 2009 | About:

Research Frontiers Inc. (NASDAQ:REFR) filed Quarterly Report for the period ended 2009-06-30.

RESEARCH FRONTIERS INC. is primarily engaged in the development and licensing of suspended particle technology and devices to control the transmission of light. Research Frontiers Inc. has a market cap of $57.4 million; its shares were traded at around $3.65 with and P/S ratio of 34.2.

Highlight of Business Operations:

Operating expenses increased by $456,569 for the first six

months of 2009 to $1,965,036 from $1,508,467 for the first six

months of 2008. This increase was principally the result of

increased non-cash charges to operating expenses ($275,000)

resulting from grant of restricted shares to directors, employees

and a consultant, as well as higher directors fees and expenses

($160,000) and higher patent costs ($68,000) and higher

professional fees ($58,000), partially offset by lower investor

relations/marketing costs ($32,000) as well as lower consulting

costs ($65,000).



Research and development expenditures increased by $50,802

to $795,763 for the first six months of 2009 from $744,961 for

the first six months of 2008. This increase was principally the

result of higher payroll and stock compensation charges

($7,000) plus higher materials costs ($61,000), partially offset

by lower allocated rent and building maintenance costs ($13,000).



As a consequence of the factors discussed above, the Company\'s

net loss was $2,422,209 ($.15 per common share) for the first

six months of 2009 as compared to $1,847,988 ($.12 per

common share) for the first six months of 2008.



Operating expenses decreased by $57,537 for the three months

ended June 30, 2009 to $648,737 from $706,274 for the three

months ended June 30, 2008. This decrease was principally the

result of lower marketing and consulting costs ($63,000) as well

as lower patent costs ($44,000) partially offset by higher

non-cash charges resulting from grant of restricted shares to

directors, employees and a consultant ($29,000) as well as lower

allocated insurance costs ($9,000).



Research and development expenditures increased by $4,327 to

$329,388 for the three months ended June 30, 2009 from

$325,061 for the three months ended June 30, 2008. This

increase was principally the result of material costs ($32,000)

partially offset by lower payroll and stock compensation charges

($11,000) as well as lower allocated insurance ($8,000) and

building occupancy costs ($10,000).



During the first six months of 2009, the Company\'s cash and

cash equivalent balance decreased by $821,066 principally as a

result of cash used to fund the Company\'s operating activities of

$2,099,031, partially offset by $1,299,756 in proceeds from the

maturity of an investment in U.S. Treasury Securities. At June

30, 2009, the Company had working capital of $2,445,316 and

its shareholders\' equity was $2,800,965.



Read the The complete Report

Rating: 2.0/5 (1 vote)

Comments

Please leave your comment:


Select portfolio(s):

  • Loading...

Why you are interested?

Your selection and notes will be stored in your portfolio.

Login to add portfolio
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK